In contrast to the traditional idea that ITGβ3 is highly expressed in tumor tissues, transcriptome analysis of 336 clinical samples from TCGA showed that ITGβ3 mRNA and CNV levels in COAD were significantly lower than those in paracancerous tissues. The gene discussed is ITGB3; the disease is neoplasm.